These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 6059447)
41. Effect of rubber closures on the stability of stannous ion in reagent kits for radiopharmaceuticals. Petry NA; Shaw SM; Kessler WV; Born GS; Belcastro PF J Parenter Drug Assoc; 1979; 33(5):283-6. PubMed ID: 259650 [No Abstract] [Full Text] [Related]
42. Factors involved in the culturing of chick embryo dorsal root ganglia in the Rose chamber. Hendelman WJ; Booher J Tex Rep Biol Med; 1966; 24(1):83-9. PubMed ID: 5336104 [No Abstract] [Full Text] [Related]
43. Extraction rates of marker compounds from rubber closures for parenteral use. II. mechanism of extraction and evaluation of select extraction parameters. Boyett JB; Avis KE Bull Parenter Drug Assoc; 1976; 30(4):169-79. PubMed ID: 953369 [No Abstract] [Full Text] [Related]
44. Particulate contamination from siliconized rubber closures for freeze drying. Gebhardt U; Grumbridge NA; Knoch A PDA J Pharm Sci Technol; 1996; 50(1):24-9. PubMed ID: 8846053 [TBL] [Abstract][Full Text] [Related]
45. [Cell culture and applied biology of the neuroglia]. Nakazawa T; Komiya H Shinkei Kenkyu No Shimpo; 1969 Nov; 13(3):617-36. PubMed ID: 4904672 [No Abstract] [Full Text] [Related]
46. Similarities and differences among specific tRNA's in mammalian tissues. Taylor MW; Granger GA; Buck CA; Holland JJ Proc Natl Acad Sci U S A; 1967 Jun; 57(6):1712-9. PubMed ID: 5231406 [No Abstract] [Full Text] [Related]
47. Warehousing of pharmaceutical closures. Greene GE Bull Parenter Drug Assoc; 1977; 31(2):103-7. PubMed ID: 851669 [No Abstract] [Full Text] [Related]
48. Cholera toxins. Burrows W Annu Rev Microbiol; 1968; 22():245-68. PubMed ID: 4880644 [No Abstract] [Full Text] [Related]
49. Strategy for determining extractables from rubber packaging materials in drug products. Paskiet DM PDA J Pharm Sci Technol; 1997; 51(6):248-51. PubMed ID: 9448435 [TBL] [Abstract][Full Text] [Related]
50. Validation of elastomeric closures for parenteral use: an overview. Wood RT J Parenter Drug Assoc; 1980; 34(4):286-94. PubMed ID: 6902776 [No Abstract] [Full Text] [Related]
55. Standardization of tests for toxicity for some materials used in tissue cultures laboratory. Stárek M; Jandejsek J Prog Immunobiol Stand; 1970; 4():450-2. PubMed ID: 5482188 [No Abstract] [Full Text] [Related]
57. Interferon as viral inhibitor induced by heterologous DNA. Holstein BA; Kohan SS; De la Peña NC; Teyssie AR; Lustig ES; Pirosky RR Acta Virol; 1971 Sep; 15(5):381-6. PubMed ID: 4399136 [No Abstract] [Full Text] [Related]
58. [Materials for closures of infusion containers]. Brinkhoff O Klin Anasthesiol Intensivther; 1977; (14):46-53. PubMed ID: 926690 [No Abstract] [Full Text] [Related]
59. An evidence-based approach to medication preparation for the surgical patient at risk for latex allergy: is it time to stop being stopper poppers? Heitz JW; Bader SO J Clin Anesth; 2010 Sep; 22(6):477-83. PubMed ID: 20868972 [TBL] [Abstract][Full Text] [Related]
60. Quantitative and mechanistic measurements of container/closure integrity: viscoelastic measurements of elastomeric closures. Morton DK; Lordi NG J Parenter Sci Technol; 1988; 42(4):127-41. PubMed ID: 3183867 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]